Edward M. Rudnic, President and CEO at MiddleBrook Pharmaceuticals, Inc. (MBRK), sold 16,900 shares at $1.19 ($20K) on 2007-11-19, disclosed to the SEC on 2007-11-23.
Scheduled sale ($20k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.20 | 700 | $840 | 4.2% |
| 2 | $1.21 | 4,000 | $5K | 24.2% |
| 3 | $1.22 | 700 | $854 | 4.3% |
| 4 | $1.17 | 200 | $234 | 1.2% |
| 5 | $1.18 | 1,000 | $1K | 5.9% |
| 6 | $1.19 | 100 |
| $119 |
| 0.6% |
| 7 | $1.17 | 7,195 | $8K | 42.0% |
| 8 | $1.18 | 2,105 | $2K | 12.4% |
| 9 | $1.19 | 900 | $1K | 5.3% |
| Total | $1.19 avg | 16,900 | $20K | 100% |
| Filing → |
| MBRK | SELL | 2007-10-18 | $18K | — | Filing → |
| MBRK | SELL | 2007-10-17 | $42K | — | Filing → |
| MBRK | SELL | 2007-09-19 | $90K | — | Filing → |